Palisade Bio (PALI) Interest & Investment Income (2010 - 2021)
Palisade Bio's (PALI) quarterly Interest & Investment Income came in at $3917.0 in Q1 2021, down 70.52% year-on-year from $13289.0 in Q1 2020, and down 30.02% on a QoQ basis from $5597.0 in Q4 2020.
Palisade Bio (PALI) Interest & Investment Income (2010 - 2021) Analysis & Trends
Palisade Bio (PALI) has 12 years of Interest & Investment Income data on file, last reported at $3917.0 in Q1 2021.
- On a quarterly basis, Interest & Investment Income fell 70.52% year-over-year to $3917.0 in Q1 2021; TTM through Mar 2021 was $24160.0, a 53.56% decrease from a year earlier, with the FY2020 full-year figure at $33532.0, down 50.49% from the prior year.
- Interest & Investment Income for Q1 2021 stood at $3917.0, down from $5597.0 in the prior quarter.
- Over the last five years, Interest & Investment Income for PALI reached as high as $29000.0 in Q1 2019 and fell as low as $3917.0 in Q1 2021.
- Historically, Interest & Investment Income has averaged $14954.6 across 5 years, with a median of $15234.0 in 2019.
- Across the five-year window, Interest & Investment Income surged 87.53% in 2017 and tumbled 70.52% in 2021, its largest moves.
- Year by year, Interest & Investment Income stood at $17274.0 in 2017, then jumped by 38.35% to $23898.0 in 2018, then sank by 47.09% to $12645.0 in 2019, then plunged by 55.74% to $5597.0 in 2020, then tumbled by 30.02% to $3917.0 in 2021.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $3917.0 in Q1 2021, $5597.0 in Q4 2020, and $7731.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Palisade Bio | 413.04 Mn | 280.41 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 3,917.00 |
| Dec 31, 2020 | 5,597.00 |
| Sep 30, 2020 | 7,731.00 |
| Jun 30, 2020 | 6,915.00 |
| Mar 31, 2020 | 13,289.00 |
| Dec 31, 2019 | 12,645.00 |
| Sep 30, 2019 | 15,234.00 |
| Jun 30, 2019 | 10,852.00 |
| Mar 31, 2019 | 29,000.00 |
| Dec 31, 2018 | 23,898.00 |
| Sep 30, 2018 | 17,619.00 |
| Jun 30, 2018 | 19,514.00 |
| Mar 31, 2018 | 17,749.00 |
| Dec 31, 2017 | 17,274.00 |
| Sep 30, 2017 | 18,099.00 |
| Jun 30, 2017 | 14,013.00 |
| Mar 31, 2017 | 20,883.00 |
| Dec 31, 2016 | 16,973.00 |
| Sep 30, 2016 | 17,293.00 |
| Jun 30, 2016 | 13,433.00 |